Elon Musk’s Neuralink has selected Miami as a clinical trial site for its brain-computer interface, the second U.S. site to participate in the groundbreaking research to aid people with

Neuralink selected the University of Miami Miller School of Medicine as its second site to conduct clinical trials on the innovative idea. Levi is a neurosurgeon and clinical director for the school.

The university will become the second U.S.-based site for Neuralink's Precise Robotically Implanted Brain-Computer Interface (PRIME) study.

Elon Musk’s brain chips are coming to Miami. Musk’s startup company Neuralink has tapped the University of Miami’s Miller School of Medicine to be the second site in the country to test whether its brain chip can give people who are paralyzed the ability to use mind to wirelessly control computers,